01.12.2023 | Case report
Cyclophosphamide/Fludarabine/Rituximab
Cytomegalovirus infection reactivation and Epstein-Barr virus infection reactivation following off-label use
Erschienen in: Reactions Weekly | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event